AgeX Therapeutics, Dr Michael D. West and the Science of Biological Ageing

Dr Michael D. West
I haven’t heard from Dr West for a while. In this technical hour, two things stood out: Telomerase has never been properly developed in gene therapy and their iTR has not yet had animal trials while they wait for funding.

In this #webinar Dr Michael West, bioentrepreneur and CEO at AgeX Therapeutics discussed the work and mission of AgeX Therapeutics and their plan to extend human longevity and health. He also talked about exciting new #technologies which could fight #ageing and unlock cell immortality.

Register for upcoming #HealthyLongevity #webinar sessions at https://nus-sg.zoom.us/webinar/register/3016397215018/WN__sypkX6ZSomc7cGAkK3LbA
#NUSMedicine #webinarseries

References:
– Closing video source: https://www.youtube.com/watch?v=yoJ6LRCkNb0

Disclaimer: Opinions and advice expressed during this webinar are solely those of the speakers. They do not reflect the views or opinions of National University of Singapore, its subsidiaries, or affiliates. This webinar contains general health information that is intended to be used for informational purposes. This information is not meant to replace professional medical advice, diagnosis or treatment. It cannot be used in lieu of consulting with a licensed healthcare provider.

All Rights Reserved
All proceedings, including scientific papers presented, are only intended for limited publication. All property rights, including common law copyright, in the material are reserved expressly to the speaker or NUS. The public domain does not include any statement or presentation. The speaker and NUS reserve the right to prohibit any reproduction of sound, transcription or other uses of material presented during this course.

Source:

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注